Acute Disseminated Encephalomyelitis Clinical Trials
2 recruiting trials for Acute Disseminated Encephalomyelitis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Disseminated Encephalomyelitis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Tongji Hospital (1), University of Bern (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is biomaker levels (diagnostic_test, 1 trial).
Track Acute Disseminated Encephalomyelitis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Biomarkers in Autoimmune Disease of Nervous System
Neurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the nervous system, including the brain, spinal cord and...
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Disseminated Encephalomyelitis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Disseminated Encephalomyelitis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Disseminated Encephalomyelitis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.